These data indicate that the activation of iNKT cells using exogenous glycolipid antigens can restrain the magnitude of the TMEV-specific CD8 T cell response in WT resistant C57Bl/6 mice without significantly affecting the course of the infection. The gene discussed is CD8A; the disease is infection.